Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Cowen & Co. Maintains Outperform on TransMedics Group, Raises Price Target to $45

Cowen & Co. analyst Joshua Jennings maintains TransMedics Group (NASDAQ:TMDX) with a Outperform and raises the price target from $39 to $45.
byBenzinga Newsdesk
July 26, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Cowen & Co. analyst Joshua Jennings maintains TransMedics Group (NASDAQ:TMDX) with a Outperform and raises the price target from $39 to $45.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts